Senate Slows Down Controversial Cost-Benefit Analysis Bill
A key U.S. Senate committee canceled the markup of a controversial bill requiring regulatory agencies to submit all rules to cost-benefit analysis by the White House so it can be discussed...To view the full article, register now.
Already a subscriber? Click here to view full article